Abstract
The dominantly inherited spinocerebellar ataxias (SCAs) are a large and diverse group of neurodegenerative diseases. The most prevalent SCAs (SCA1, SCA2, SCA3, SCA6 and SCA7) are caused by expansion of a glutamine-encoding CAG repeat in the affected gene. These SCAs represent a substantial portion of the polyglutamine neurodegenerative disorders and provide insight into this class of diseases as a whole. Recent years have seen considerable progress in deciphering the clinical, pathological, physiological and molecular aspects of the polyglutamine SCAs, with these advances establishing a solid base from which to pursue potential therapeutic approaches.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 613-626 |
| Number of pages | 14 |
| Journal | Nature Reviews Neuroscience |
| Volume | 18 |
| Issue number | 10 |
| DOIs | |
| State | Published - Sep 19 2017 |
Bibliographical note
Publisher Copyright:© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.